Current and new antitumor necrosis factor agents in perspective

被引：5

作者：

Maini, RN ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London W6 8LH, England

来源：

ARTHRITIS RESEARCH & THERAPY | 2004年 / 6卷 / Suppl 2期

关键词：

D O I：

10.1186/ar994

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S1 / S2

页数：2

共 17 条

[1]

*ABB LAB, 2002, HUM PACK INS

[2]

*AM COLL RHEUM, FDA ADV COMM REV SAF

[3]

BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293

[4]

*CENT INC, 2002, REM PACK INS

[5] Taming TNF: strategies to restrain this proinflammatory cytokine [J].

Eigler, A ;

Sinha, B ;

Hartmann, G ;

Endres, S .

IMMUNOLOGY TODAY, 1997, 18 (10) :487-492

[6] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

KALDEN, JR ;

ANTONI, C ;

SMOLEN, JS ;

LEEB, B ;

BREEDVELD, FC ;

MACFARLANE, JD ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1105-1110

[7]

ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362

[8] Anti-TNFα therapy of rheumatoid arthritis:: what have we learned? [J].

Feldmann, M ;

Maini, RN .

ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :163-196

[9] Role of cytokines in rheumatoid arthritis [J].

Feldmann, M ;

Brennan, FM ;

Maini, RN .

ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :397-440

[10]

Geborek P, 2001, AM COLL RHEUM 65 ANN

← 1 2 →